Kovitz Investment Group Partners LLC Increases Stock Position in VanEck Biotech ETF (NASDAQ:BBH)

Kovitz Investment Group Partners LLC lifted its position in VanEck Biotech ETF (NASDAQ:BBH) by 4.6% in the third quarter, Holdings Channel reports. The firm owned 3,186 shares of the company’s stock after acquiring an additional 141 shares during the period. Kovitz Investment Group Partners LLC’s holdings in VanEck Biotech ETF were worth $565,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. International Assets Investment Management LLC boosted its stake in shares of VanEck Biotech ETF by 10,376,390.9% during the third quarter. International Assets Investment Management LLC now owns 1,141,414 shares of the company’s stock worth $202,475,000 after buying an additional 1,141,403 shares during the period. Northwestern Mutual Wealth Management Co. lifted its position in VanEck Biotech ETF by 5.8% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 24,324 shares of the company’s stock worth $4,096,000 after acquiring an additional 1,334 shares during the period. Atlas Capital Advisors LLC acquired a new stake in VanEck Biotech ETF during the 2nd quarter worth approximately $960,000. Truist Financial Corp grew its stake in shares of VanEck Biotech ETF by 3.8% in the 2nd quarter. Truist Financial Corp now owns 2,703 shares of the company’s stock valued at $455,000 after purchasing an additional 100 shares during the last quarter. Finally, Tyler Stone Wealth Management increased its holdings in shares of VanEck Biotech ETF by 79.5% in the third quarter. Tyler Stone Wealth Management now owns 1,472 shares of the company’s stock valued at $261,000 after purchasing an additional 652 shares during the period. Hedge funds and other institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Stock Down 1.0 %

Shares of NASDAQ BBH opened at $164.53 on Friday. The stock has a fifty day moving average price of $169.87 and a 200 day moving average price of $172.97. VanEck Biotech ETF has a 1-year low of $151.35 and a 1-year high of $183.64.

VanEck Biotech ETF Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.